ZA946881B - Methods for treating gastrointestinal motility - Google Patents
Methods for treating gastrointestinal motilityInfo
- Publication number
- ZA946881B ZA946881B ZA946881A ZA946881A ZA946881B ZA 946881 B ZA946881 B ZA 946881B ZA 946881 A ZA946881 A ZA 946881A ZA 946881 A ZA946881 A ZA 946881A ZA 946881 B ZA946881 B ZA 946881B
- Authority
- ZA
- South Africa
- Prior art keywords
- methods
- gastrointestinal motility
- treating gastrointestinal
- gastric emptying
- motility
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/23—Calcitonins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11838193A | 1993-09-07 | 1993-09-07 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA946881B true ZA946881B (en) | 1995-10-30 |
Family
ID=22378228
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA946881A ZA946881B (en) | 1993-09-07 | 1994-09-07 | Methods for treating gastrointestinal motility |
Country Status (23)
Country | Link |
---|---|
US (4) | US6114304A (pt) |
EP (1) | EP0717635B1 (pt) |
JP (2) | JP3821839B2 (pt) |
KR (2) | KR100391399B1 (pt) |
CN (1) | CN1134110A (pt) |
AT (1) | ATE197549T1 (pt) |
AU (1) | AU7685894A (pt) |
BG (1) | BG100463A (pt) |
BR (1) | BR9407424A (pt) |
CA (1) | CA2171207C (pt) |
CZ (1) | CZ69596A3 (pt) |
DE (1) | DE69426304T2 (pt) |
DK (1) | DK0717635T3 (pt) |
ES (1) | ES2154299T3 (pt) |
GR (1) | GR3035387T3 (pt) |
HU (1) | HUT73490A (pt) |
NO (1) | NO960899L (pt) |
PT (1) | PT717635E (pt) |
RU (1) | RU2177331C2 (pt) |
SG (1) | SG98356A1 (pt) |
SK (1) | SK31496A3 (pt) |
WO (1) | WO1995007098A1 (pt) |
ZA (1) | ZA946881B (pt) |
Families Citing this family (65)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7138486B2 (en) | 1986-05-05 | 2006-11-21 | The General Hospital Corporation | Insulinotropic hormone derivatives and uses thereof |
US5614492A (en) * | 1986-05-05 | 1997-03-25 | The General Hospital Corporation | Insulinotropic hormone GLP-1 (7-36) and uses thereof |
US6849708B1 (en) | 1986-05-05 | 2005-02-01 | The General Hospital Corporation | Insulinotropic hormone and uses thereof |
HU222249B1 (hu) * | 1991-03-08 | 2003-05-28 | Amylin Pharmaceuticals Inc. | Eljárás amilin agonista peptidszármazékok és ezeket tartalmazó gyógyszerkészítmények előállítására |
US6284727B1 (en) | 1993-04-07 | 2001-09-04 | Scios, Inc. | Prolonged delivery of peptides |
CA2171207C (en) * | 1993-09-07 | 2010-03-30 | Orville G. Kolterman | Methods for regulating gastrointestinal motility |
US6143718A (en) * | 1995-06-07 | 2000-11-07 | Amylin Pharmaceuticals, Inc. | Treatment of Type II diabetes mellutis with amylin agonists |
ATE417622T1 (de) | 1996-08-08 | 2009-01-15 | Amylin Pharmaceuticals Inc | Regulation gastrointestinaler beweglichkeit |
WO1998030231A1 (en) | 1997-01-07 | 1998-07-16 | Amylin Pharmaceuticals, Inc. | Use of exendins and agonists thereof for the reduction of food intake |
US7101853B2 (en) * | 1997-05-06 | 2006-09-05 | Amylin Pharmaceuticals, Inc. | Method for treating or preventing gastritis using amylin or amylin agonists |
US7910548B2 (en) * | 1997-06-06 | 2011-03-22 | Amylin Pharmaceuticals, Inc. | Methods for treating obesity |
EP1053001B1 (en) * | 1998-02-13 | 2010-12-15 | Amylin Pharmaceuticals, Inc. | Novel mixed amylin activity compounds |
US6936584B1 (en) | 1998-02-13 | 2005-08-30 | Amylin Pharmaceuticals, Inc. | Mixed amylin activity compounds |
ATE460942T1 (de) | 1999-01-14 | 2010-04-15 | Amylin Pharmaceuticals Inc | Exendine zur glucagon suppression |
US6902744B1 (en) | 1999-01-14 | 2005-06-07 | Amylin Pharmaceuticals, Inc. | Exendin agonist formulations and methods of administration thereof |
US7399489B2 (en) | 1999-01-14 | 2008-07-15 | Amylin Pharmaceuticals, Inc. | Exendin analog formulations |
US6924264B1 (en) | 1999-04-30 | 2005-08-02 | Amylin Pharmaceuticals, Inc. | Modified exendins and exendin agonists |
US6528486B1 (en) | 1999-07-12 | 2003-03-04 | Zealand Pharma A/S | Peptide agonists of GLP-1 activity |
US6451806B2 (en) | 1999-09-29 | 2002-09-17 | Adolor Corporation | Methods and compositions involving opioids and antagonists thereof |
US6469030B2 (en) | 1999-11-29 | 2002-10-22 | Adolor Corporation | Methods for the treatment and prevention of ileus |
JP2004514462A (ja) | 2000-03-03 | 2004-05-20 | シー・アール・バード・インク | 複数吸引ポート付き内視鏡用組織癒着装置 |
ES2435094T3 (es) | 2000-05-19 | 2013-12-18 | C.R. Bard, Inc. | Dispositivo y método de captura y sutura de tejido |
US6451813B1 (en) | 2001-01-26 | 2002-09-17 | R. T. Alamo Ventures I, Llc | Treatment of gastroparesis in certain patient groups |
WO2004024192A1 (en) * | 2002-09-12 | 2004-03-25 | University Of Chicago | Monitoring and diagnosis of gastric emptying and gastroparesis |
US8168233B2 (en) * | 2002-10-18 | 2012-05-01 | Amylin Pharmaceuticals, Inc. | Treatment of pancreatitis with amylin |
WO2004060387A1 (en) * | 2002-12-27 | 2004-07-22 | Diobex, Inc. | Compositions and methods for the prevention and control of insulin-induced hypoglycemia |
US7655618B2 (en) * | 2002-12-27 | 2010-02-02 | Diobex, Inc. | Compositions and methods for the prevention and control of insulin-induced hypoglycemia |
EP1663289A2 (en) * | 2003-08-29 | 2006-06-07 | Amylin Pharmaceuticals, Inc. | Methods for treating or ameliorating ghrelin-associated diseases and disorders |
CA2556226A1 (en) | 2004-02-11 | 2006-08-10 | Amylin Pharmaceuticals, Inc. | Amylin family peptides and methods for making and using them |
US7399744B2 (en) * | 2004-03-04 | 2008-07-15 | Amylin Pharmaceuticals, Inc. | Methods for affecting body composition |
US7878978B2 (en) | 2004-03-18 | 2011-02-01 | University Of Pittsburgh- Of The Commonwealth System Of Higher Education | Use of relaxin to increase arterial compliance |
US8172857B2 (en) | 2004-08-27 | 2012-05-08 | Davol, Inc. | Endoscopic tissue apposition device and method of use |
EP2127676A3 (en) | 2004-11-01 | 2013-09-04 | Amylin Pharmaceuticals, LLC | Treatment of obesity and related disorders |
US8394765B2 (en) * | 2004-11-01 | 2013-03-12 | Amylin Pharmaceuticals Llc | Methods of treating obesity with two different anti-obesity agents |
EP1888094B1 (en) | 2005-03-31 | 2009-08-12 | Amylin Pharmaceuticals, Inc. | Amylin and amylin agonists for treating psychiatric diseases and disorders |
ES2397659T3 (es) | 2006-03-15 | 2013-03-08 | Novo Nordisk A/S | Mezclas de amilina e insulina |
CN101405020A (zh) * | 2006-03-23 | 2009-04-08 | 安米林药品公司 | 代谢疾病治疗中的内皮素和内皮素受体激动剂 |
US20090181890A1 (en) * | 2006-03-31 | 2009-07-16 | Amylin Pharmaceuticals , Inc. | Amylin and Amylin Agonists for Treating Psychiatric Diseases and Disorders |
ES2389747T3 (es) | 2007-02-05 | 2012-10-31 | Amylin Pharmaceuticals, Inc. | Péptidos FN-38 para su uso en el tratamiento de desórdenes psicóticos y de ansiedad |
KR20100098628A (ko) * | 2007-11-14 | 2010-09-08 | 아밀린 파마슈티칼스, 인크. | 비만 및 비만 관련 질환 및 장애의 치료 방법 |
KR101673042B1 (ko) | 2009-03-12 | 2016-11-04 | 키바이오사이언스 아게 | 당뇨병 및 대사 증후군의 치료 |
WO2010107874A2 (en) * | 2009-03-17 | 2010-09-23 | Amylin Pharmaceuticals, Inc. | Methods for affecting body composition using amylin agonists |
KR20130098873A (ko) | 2010-04-27 | 2013-09-05 | 질랜드 파마 에이/에스 | Glp-1 수용체 작용제 및 가스트린의 펩타이드 접합체 및 그의 용도 |
AR088636A1 (es) | 2011-11-03 | 2014-06-25 | Zealand Pharma As | Conjugados peptidicos de un agonista del receptor de glp-1 y gastrina |
CN104662038B (zh) | 2012-07-23 | 2018-11-06 | 西兰制药公司 | 胰高血糖素类似物 |
TWI608013B (zh) | 2012-09-17 | 2017-12-11 | 西蘭製藥公司 | 升糖素類似物 |
US9988429B2 (en) | 2013-10-17 | 2018-06-05 | Zealand Pharma A/S | Glucagon analogues |
MY176022A (en) | 2013-10-17 | 2020-07-21 | Boehringer Ingelheim Int | Acylated glucagon analogues |
KR102310389B1 (ko) | 2013-11-06 | 2021-10-13 | 질랜드 파마 에이/에스 | Gip-glp-1 이원 효능제 화합물 및 방법 |
TR201902516T4 (tr) | 2013-11-06 | 2019-03-21 | Zealand Pharma As | Glukagon-glp-1-gıp üçlü agonist bileşikleri. |
WO2015196174A1 (en) | 2014-06-20 | 2015-12-23 | Greene Howard E | Infusion delivery devices and methods |
DK3212218T3 (da) | 2014-10-29 | 2021-08-30 | Zealand Pharma As | GIP-agonistforbindelser og fremgangsmåder |
EP3271381B1 (en) | 2015-03-18 | 2021-09-08 | Zealand Pharma A/S | Amylin analogues |
CN107636010B (zh) | 2015-04-16 | 2021-10-01 | 西兰制药公司 | 酰化胰高血糖素类似物 |
US10071140B2 (en) | 2016-09-09 | 2018-09-11 | Zealand Pharma A/S | Amylin analogues |
CA3043151A1 (en) | 2016-12-09 | 2018-06-14 | Zealand Pharma A/S | Acylated glp-1/glp-2 dual agonists |
WO2018122278A1 (fr) | 2016-12-27 | 2018-07-05 | Adocia | Compositions sous forme de solution aqueuse injectable comprenant de l'amyline, un agoniste au récepteur de l'amyline ou un analogue d'amyline et un co-polyaminoacide |
ES2917893T3 (es) | 2017-07-27 | 2022-07-12 | Adocia | Composiciones en forma de una solución acuosa inyectable que comprenden al menos insulina humana A21G y un supresor de glucagón con acción prandial |
MX2020005916A (es) | 2017-12-07 | 2020-10-19 | Adocia | Composiciones en forma de una solución acuosa inyectable que comprende amilina, un receptor agonista de amilina o un análogo de amilina y un copoliaminoácido. |
FR3083086A1 (fr) | 2018-06-29 | 2020-01-03 | Adocia | Compositions sous forme d'une solution aqueuse injectable comprenant de l'amyline, un agoniste au recepteur de l'amyline ou un analogue d'amyline et un co-polyaminoacide |
CN111683674A (zh) | 2017-12-07 | 2020-09-18 | 阿道恰公司 | 包含胰淀素、胰淀素激动剂受体或胰淀素类似物和共聚氨基酸的可注射水溶液形式的组合物 |
WO2019115411A1 (fr) | 2017-12-07 | 2019-06-20 | Adocia | Compositions sous forme d'une solution aqueuse injectable comprenant de l'amyline, un agoniste au recepteur de l'amyline ou un analogue d'amyline et un co-polyaminoacide |
FR3083085B1 (fr) | 2018-06-29 | 2020-10-02 | Adocia | Compositions sous forme d'une solution aqueuse injectable comprenant de l'amyline, un agoniste au recepteur de l'amyline ou un analogue d'amyline et un co-polyaminoacide |
WO2019110797A1 (fr) | 2017-12-07 | 2019-06-13 | Adocia | Compositions sous forme d'une solution aqueuse injectable comprenant de l'amyline, un agoniste au recepteur de l'amyline ou un analogue d'amyline et un co-polyaminoacide |
FR3084586B1 (fr) | 2018-08-03 | 2020-11-06 | Adocia | Compositions sous forme d'une solution aqueuse injectable comprenant de l'amyline, un agoniste au recepteur de l'amyline ou un analogue d'amyline et un compose amphiphile porteur de radicaux hydrophobes |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4451394A (en) * | 1982-10-25 | 1984-05-29 | American Home Products Corporation | Dodecapeptides preventing glucose and triglyceride assimilation |
US4530838A (en) * | 1983-07-08 | 1985-07-23 | The Salk Institute For Biological Studies | Synthetic calcitonin-gene-related peptides for lowering blood pressure or gastric acid secretion in mammals |
US4690486A (en) * | 1985-04-29 | 1987-09-01 | Texas Instruments Incorporated | Four position interlacing apparatus |
GB8720115D0 (en) * | 1987-08-26 | 1987-09-30 | Cooper G J S | Treatment of diabetes mellitus |
GB8709871D0 (en) * | 1987-04-27 | 1987-06-03 | Turner R C | Peptides |
US5367052A (en) * | 1987-04-27 | 1994-11-22 | Amylin Pharmaceuticals, Inc. | Amylin peptides |
US5266561A (en) * | 1988-01-11 | 1993-11-30 | Amylin Pharmaceuticals, Inc. | Treatment of type 2 diabetes mellitus |
US5175145A (en) * | 1988-08-26 | 1992-12-29 | Amylin Pharmaceuticals, Inc. | Treatment of diabetes mellitus with amylin agonists |
US5166192A (en) * | 1989-05-09 | 1992-11-24 | Mathias John R | Treatment of motility disorders with a GnRH analog |
US5260275A (en) * | 1990-08-14 | 1993-11-09 | Amylin Pharmaceuticals, Inc. | Hypoglycemics |
US5187154A (en) * | 1990-12-13 | 1993-02-16 | Board Of Regents, The University Of Texas System | Diagnosis and treatment of humans with diabetes or at risk to develop diabetes |
US5234906A (en) * | 1991-01-10 | 1993-08-10 | Amylin Pharmaceuticals, Inc. | Hyperglycemic compositions |
US5264372A (en) * | 1991-03-15 | 1993-11-23 | Amylin Pharmaceuticals, Inc. | Receptor-based screening methods for amylin agonists and antagonists |
HU222249B1 (hu) * | 1991-03-08 | 2003-05-28 | Amylin Pharmaceuticals Inc. | Eljárás amilin agonista peptidszármazékok és ezeket tartalmazó gyógyszerkészítmények előállítására |
DK0586589T3 (da) * | 1991-05-24 | 1997-09-22 | Amylin Pharmaceuticals Inc | Amylin- eller amylinanalogpræparat, som eventuelt indeholder insulin, til behandling af anoreksi og beslægtede tilstande |
US5580953A (en) * | 1991-08-14 | 1996-12-03 | Amylin Pharmaceuticals, Inc. | Amylin antagonist peptides and uses therefor |
JP2902115B2 (ja) * | 1991-11-19 | 1999-06-07 | アミリン・ファーマシューティカルズ,インコーポレイテッド | 新規アミリン作動薬ペプチドおよびその使用 |
US5376638A (en) * | 1992-09-01 | 1994-12-27 | Amylin Pharmaceuticals, Inc. | Methods for treating renin-related disorders with amylin antagonists |
WO1994020116A1 (en) * | 1993-03-10 | 1994-09-15 | University Of Alabama Research Foundation | Artificial primers for glycogen synthesis |
CA2171207C (en) * | 1993-09-07 | 2010-03-30 | Orville G. Kolterman | Methods for regulating gastrointestinal motility |
US6143718A (en) * | 1995-06-07 | 2000-11-07 | Amylin Pharmaceuticals, Inc. | Treatment of Type II diabetes mellutis with amylin agonists |
-
1994
- 1994-09-07 CA CA2171207A patent/CA2171207C/en not_active Expired - Lifetime
- 1994-09-07 ZA ZA946881A patent/ZA946881B/xx unknown
- 1994-09-07 SK SK314-96A patent/SK31496A3/sk unknown
- 1994-09-07 DK DK94927398T patent/DK0717635T3/da active
- 1994-09-07 KR KR1019960701160A patent/KR100391399B1/ko not_active IP Right Cessation
- 1994-09-07 ES ES94927398T patent/ES2154299T3/es not_active Expired - Lifetime
- 1994-09-07 PT PT94927398T patent/PT717635E/pt unknown
- 1994-09-07 EP EP94927398A patent/EP0717635B1/en not_active Expired - Lifetime
- 1994-09-07 DE DE69426304T patent/DE69426304T2/de not_active Expired - Lifetime
- 1994-09-07 US US08/302,069 patent/US6114304A/en not_active Expired - Lifetime
- 1994-09-07 SG SG9607979A patent/SG98356A1/en unknown
- 1994-09-07 BR BR9407424A patent/BR9407424A/pt not_active Application Discontinuation
- 1994-09-07 AU AU76858/94A patent/AU7685894A/en not_active Abandoned
- 1994-09-07 KR KR10-2003-7005868A patent/KR100429966B1/ko not_active IP Right Cessation
- 1994-09-07 HU HU9600558A patent/HUT73490A/hu unknown
- 1994-09-07 WO PCT/US1994/010225 patent/WO1995007098A1/en active IP Right Grant
- 1994-09-07 RU RU96107891/14A patent/RU2177331C2/ru active
- 1994-09-07 AT AT94927398T patent/ATE197549T1/de active
- 1994-09-07 CN CN94193931A patent/CN1134110A/zh active Pending
- 1994-09-07 CZ CZ96695A patent/CZ69596A3/cs unknown
- 1994-09-07 JP JP50882395A patent/JP3821839B2/ja not_active Expired - Lifetime
-
1995
- 1995-06-05 US US08/471,675 patent/US5795861A/en not_active Expired - Lifetime
-
1996
- 1996-03-06 NO NO960899A patent/NO960899L/no unknown
- 1996-03-29 BG BG100463A patent/BG100463A/xx unknown
-
2000
- 2000-05-22 US US09/576,062 patent/US6608029B1/en not_active Expired - Fee Related
-
2001
- 2001-02-07 GR GR20010400214T patent/GR3035387T3/el unknown
-
2003
- 2003-08-18 US US10/643,681 patent/US7407934B2/en not_active Expired - Fee Related
-
2004
- 2004-08-11 JP JP2004234571A patent/JP2004331674A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA946881B (en) | Methods for treating gastrointestinal motility | |
CA2262647A1 (en) | Methods for regulating gastrointestinal motility | |
NZ504258A (en) | Exendin 3 and 4 agonist compounds for the treatment of diabetes | |
CA2274596A1 (en) | Compositions and methods for enhancing intestinal function | |
CY1107752T1 (el) | Xρηση των εξενδινων και αγωνιστων τους για τη θεραπεια του σακχαρωδους διαβητη της κυησης | |
HK1042496A1 (en) | Novel heteroaromatic inhibitors of fructose 1,6-bishosphatase | |
EP1618898A3 (en) | Methods for regulating angiogenesis | |
NZ502610A (en) | Use of lactobacillus for reduction of the fibrinogen level in blood | |
NZ504256A (en) | Exendin 3 and 4 agonist compounds for treating diabetes | |
CA2257077A1 (en) | Treatment of diarrhea | |
LT2002063A (en) | Low-dose metformin and gliburide combinations for treating diabetes | |
WO2003000242A3 (en) | Method for the treatment of lymphedema using guaifenesin | |
GR3031250T3 (en) | Methods of diagnosing and treating preeclampsia | |
DE69920885D1 (en) | C-myc-bindendes protein "c-myc coding region determinant-binding protein (crd-bp)" | |
CA2340320A1 (en) | Use of an angiogenic factor for the treatment of microascular angiopathies | |
HK1047707A1 (zh) | (+)-曲馬朵、o-去甲曲馬朵或(+)-o-去甲曲馬朵、o-去甲-n-單-去甲-曲馬朵或(+)-o-去甲-n-單-去甲-曲馬朵治療尿失禁的用途 | |
UA50761C2 (uk) | Спосіб запобігання та/або лікування серцевих захворювань, фармацевтична композиція та спосіб запобігання та/або лікування серцевої недостатності та дисфункції шлуночків в організмі теплокровної тварини | |
CA2327439A1 (en) | Combination therapy for the treatment of tumors | |
WO1992018536A3 (en) | Method for detecting an localizing tissues having neurokinine 1 receptors | |
AP2000001950A0 (en) | Paroxetine maleate. | |
EP1417971A3 (en) | Use of an angiogenic factor for the treatment of microvascular angiopathies | |
AU6648200A (en) | Method and composition for preventing or treating adverse physiological effects associated with cardiac disease | |
WO1999064065A3 (en) | Tumour therapy and imaging | |
PT979098E (pt) | Metodo para o tratamento da hiperprolactinemia e de prolactinomas | |
ES8602799A1 (es) | Un procedimiento para preparar 6-metilsulfoxido-espiro-(croman-4,4'-imidazolidin)-2',5'-diona |